Security key
74168J101
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 58,654,950
- Total 13F value
- $144,864,309
- Share change
- -1,667,943
- Put/Call ratio
- 116%
- SEC-reported price per share
- $2.47
- Number of holders
- 118
- Value change
- -$2,708,584
- Number of buys
- 64
- Number of sells
- 64
- Shares outstanding
- 181,672,212
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
118
Top holders
10
PRME full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Prime Medicine, Inc. SEC filings
Prime Medicine, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74168J101
Recent filing periods:
Ownership snapshot
Top reported holders of PRME - Prime Medicine, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Newpath Partners, L.P.
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
3/4/5
13F
Lead comparable stake: 4.7%
13D/G row: Newpath Partners, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Newpath Partners, L.P. leads the comparable SEC ownership view at 4.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Newpath Partners, L.P.'s linked filing trail.
Comparable ownership
Top 5
Newpath Partners, L.P.
4.7%
David R. Liu
11%
Alphabet Inc.
8.3%
BlackRock, Inc.
2.4%
T. Rowe Price Investment Manageme...
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Newpath Partners, L.P. |
13D/G
|
4.7%
|
$9,769,086
6,105,679 shares
|
$0 | 31 Dec 2024 |
| David R. Liu |
3/4/5
10%+ Owner
|
11%
|
$50,920,145
20,240,945 shares
|
— | 30 Jun 2025 |
| Alphabet Inc. |
13F
Company
|
8.3%
|
$29,974,371
15,062,498 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
2.4%
|
$8,569,360
4,306,211 shares
|
— | 31 Mar 2025 |
| T. Rowe Price Investment Management, Inc. |
13F
Company
|
2.3%
|
$8,245,000
4,143,096 shares
|
— | 31 Mar 2025 |
| FMR LLC |
3/4/5
13F
Other* · Company
|
2.1%
from 13F
|
$126,699,612
8,462,946 shares
|
— | 24 Oct 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
118
Shares
58,654,950
Rows available
118
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
121
Q2 2025 holders
118
Holder diff
-3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend